MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis
Publication year
2019Source
Expert Opinion on Biological Therapy, 19, 7, (2019), pp. 721-733ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Laboratory Medicine
Journal title
Expert Opinion on Biological Therapy
Volume
vol. 19
Issue
iss. 7
Page start
p. 721
Page end
p. 733
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227942]
- Electronic publications [107434]
- Faculty of Medical Sciences [86237]
- Open Access publications [76544]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.